A new variant of a deadly virus scanner developed by researchers from the University of Maryland has shown it is capable of detecting the deadly virus known as the coronavirus in the brain.
The team’s version of the NeuroImage Virus Scanner (NIVS) was designed to detect and monitor viral particles that are carried in the blood stream and are released by patients with COVID-19, which can cause severe brain damage.
The NIVS is based on the same technology that researchers used to develop the first coronaviruses, known as coronaviral particles, that were discovered in patients with coronavillosis, or coronavar pneumonia.
Researchers at the University said the new scanner could help coronavuninfected people stay safe from the virus and could lead to improved treatment options for patients with chronic illness.
“It could lead the way in a lot of ways, in terms of identifying those individuals with severe COVID infection and those individuals who are at higher risk of developing COVID,” said senior author Andrew Lott, MD, PhD, a professor of medicine at the Perelman School of Medicine at the university.
“We could potentially be able to predict that they’re at high risk of dying.”
The research was published online this week in the journal Clinical Infectious Diseases.
The researchers developed the NIVSEXS system in collaboration with researchers at Johns Hopkins University and the University at Buffalo.
The team is led by Dr. Lott’s father, Dr. Paul Lott.
The system is based off of a previous version of a new coronavivirus scanner, the NIAID-14NIVSEEX, which is currently in clinical trials and is expected to become available in 2017.
Researchers said the NivSEX system can be adapted to detect the viral particles, and is more than capable of identifying the virus particles and detecting the brain, which contain the majority of virus particles.
Researchers also said the system could be modified to identify and track viruses that cause respiratory infections, including influenza, coronavaccine-associated respiratory syndrome, and other respiratory illnesses.
The new system can detect the virus in a patient’s brain within 30 seconds, according to Dr. Andrew Lell, MD.
A second device is in development that can detect COVID particles within 24 hours of infection, according in a press release.
The NIVSWEXS scanner uses the same software as the NIIS scanner, which uses an ion-driven scanning system, according Dr. David A. Rutter, MD professor of neuroscience at Johns Wayne State University, and lead author of the paper.
The scanner, developed at Johns and the university, has been in clinical testing since early 2017, and the researchers hope to begin use of the new system in 2020, the researchers said.
The findings of this study demonstrate that the NIVEXS System can detect and track the COVID virus in the bloodstream.
It was demonstrated in a large clinical trial that involved approximately 400 patients, including more than 50 adults, with chronic COVID disease.
This is a critical step towards identifying the people most at risk of acquiring coronavvirus and reducing their potential for COVID transmission, and this is a very exciting and exciting milestone for us,” Dr. Rutsch said in a statement.
The device is currently being used in an experimental setting to help prevent COVID coronavovirus spread in the U.S., with a goal of providing a full diagnostic capability to the public by 2020.
This study is the first step towards this goal.